Discovery and Biological Evaluation of a Novel and Highly Potent JAK2 Inhibitor for the Treatment of Triple Negative Breast Cancer

Investigators discovered six JAK2 inhibitors using structure-based virtual screening and molecular docking and demonstrated that JNN-5 may be a highly effective and selective antitumor compound for the treatment of TNBC.